Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$595K Buy
+20,869
New +$454K 0.1% 402
2024
Q4
Sell
-9,088
Closed -$284K 903
2024
Q3
$284K Sell
9,088
-16,850
-65% -$419K 0.06% 568
2024
Q2
$403K Buy
25,938
+12,416
+92% +$150K 0.08% 482
2024
Q1
$143K Buy
+13,522
New +$135K 0.03% 676
2022
Q4
Sell
-10,869
Closed -$185K 645
2022
Q3
$185K Buy
+10,869
New +$233K 0.07% 493
2018
Q3
Sell
-14,580
Closed -$178K 598
2018
Q2
$178K Buy
+14,580
New +$167K 0.06% 589

Other funds holding CDNA

Fox Run Management's CDNA Position: Q2 2026 in Review

Fox Run Management opened a new position in CareDx (CDNA) in Q2 2026: 20,869 shares worth $595K. The stake represents 0.1% of the portfolio and ranks #402 among its holdings. This is a return to the name: Fox Run Management previously reported a position in CDNA as recently as Q3 2024.

Fox Run Management first reported a position in CDNA in Q2 2018 and has held it in 6 quarters since. 228 funds tracked by Wall St. Rank hold CDNA as of Q2 2026.

  • Fox Run Management held 20,869 shares of CareDx worth $595K as of Q2 2026.
  • CareDx was a new Fox Run Management position in Q2 2026.
  • CareDx made up 0.1% of Fox Run Management's portfolio in Q2 2026, its #402 holding.
  • Fox Run Management first reported a position in CareDx in Q2 2018 and has held it in 6 quarters since.
  • 228 funds tracked by Wall St. Rank held CareDx as of Q2 2026.

Based on Fox Run Management's 13F filing for Q2 2026, filed 4 Aug 2026.